Nurix Therapeutics NRIX
NASDAQ NRIX
$23.70 +0.03 (+0.11%)
As of: Sep 30, 2026 · 12:52 PM EDT

Nurix Therapeutics, Inc. (NRIX) Current Deferred Revenue (2019 - 2026)

Updated

Nurix Therapeutics' Current Deferred Revenue was $13.32 million in fiscal Q2 2026 (quarter ended May 31, 2026), down 51.4% from $27.42 million a year earlier and down 29.0% from the prior quarter.

Analysis

Nurix Therapeutics, Inc. (NRIX) Current Deferred Revenue (2019 - 2026) Analysis & Trends

At the end of FY2025 (ended Nov 30, 2025), Current Deferred Revenue at Nurix Therapeutics came in at $17.58 million, down 54.2% from FY2024.

  • Current Deferred Revenue shows a five-year compound annual growth rate of -11.7% (FY2020 to FY2025).
  • In earlier fiscal years, Current Deferred Revenue was $38.36 million in FY2024 (-20.2%), $48.1 million in FY2023 (+27.8%), $37.63 million in FY2022 (-8.7%) and $41.21 million in FY2021 (+25.7%).
  • The fiscal Q2 2026 figure marks the lowest quarterly Current Deferred Revenue since fiscal Q4 2019.
  • Compared with a year earlier, Current Deferred Revenue has declined for seven straight quarters, with an average decline of 29.4% over the last eight quarters.
  • The best year-over-year quarter for Current Deferred Revenue over five years was fiscal Q3 2024 (growth of 49.8%); the worst was fiscal Q4 2025 (a decline of 54.2%).
  • Per Business Quant data, NRIX's Current Deferred Revenue in the three fiscal quarters before Q2 2026 was $18.75 million (Q1 2026), $17.58 million (Q4 2025) and $25.99 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 13.32 Mn
Feb 28, 2026 18.75 Mn
Nov 30, 2025 17.58 Mn
Aug 31, 2025 25.99 Mn
May 31, 2025 27.42 Mn
Feb 28, 2025 30.59 Mn
Nov 30, 2024 38.36 Mn
Aug 31, 2024 48.00 Mn
May 31, 2024 46.77 Mn
Feb 29, 2024 46.08 Mn
Nov 30, 2023 48.10 Mn
Aug 31, 2023 32.04 Mn
May 31, 2023 44.06 Mn
Feb 28, 2023 38.31 Mn
Nov 30, 2022 37.63 Mn
Aug 31, 2022 36.34 Mn
May 31, 2022 41.32 Mn
Feb 28, 2022 43.19 Mn
Nov 30, 2021 41.21 Mn
Aug 31, 2021 35.25 Mn
API Access

Nurix Therapeutics, Inc. Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=NRIX&period=max&api_key=YOUR_API_KEY